Lumeon today announced that it has secured £6 million ($9.4 million) from a Series B funding round. New investment partner, Gilde Healthcare Partners, led this funding round which included existing investors, Amadeus Capital Partners and Archimedia Investments.

This investment supports Lumeon’s pioneering Care Pathway Management (CPM) platform that provides a single, real-time view of the entire patient journey, from referral to outcome. For providers, a care pathway approach to healthcare delivery is measurable, both in terms of efficiency and outcome; predictable so that demand is visible and can be anticipated; and controlled, eliminating unwanted variance.

Robbie Hughes, CEO and founder, Lumeon commented: “Whilst every clinician would intuitively recognise that healthcare is a personalised experience, delivering personalisation at scale has been impossible to date with different systems and stakeholders owning different parts of the patient journey. Lumeon looks at the problem differently, providing a single platform to join up pathways across specialties and systems, giving visibility and control to providers.”

As part of the investment, Janke Dittmer, partner at Gilde Healthcare, joins the Board as a Non-Executive Director and Erik Masing as an Advisor.  Additionally, Lumeon has strengthened its executive team with the introduction of Andrew Wyatt as Chief Operating Officer. Andrew brings a depth of experience in successfully scaling software and SaaS businesses, including BroadSoft Inc (NASDAQ: BSFT) where he was VP Strategy and Apertio Ltd. where he was Chief Product Operations Officer and interim CEO.

Gilde Healthcare Managing Partner Janke Dittmer noted: “Healthcare providers are being challenged to provide better care at lower cost in an environment that is changing at an increasing pace. Lumeon enables healthcare providers to adapt to the changing needs of patients, providers and payers.  We look forward to working with Lumeon to successfully scale the business to address this clearly identified need.”

Gilde Healthcare (Utrecht, The Netherlands and Cambridge, Massachusetts, US) is a private equity investor focused on fast growing healthcare businesses. It manages €550 million across two business lines. The Gilde Healthcare Technology funds target companies developing home & digital health solutions, medical devices and medicines in Europe and the USA.

For more information, please visit